These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 36114906)

  • 1. Sperm quality is not affected by the BNT162b2 mRNA SARS-CoV-2 vaccine: results of a 6-14 months follow-up.
    Karavani G; Chill HH; Meirman C; Gutman-Ido E; Herzberg S; Tzipora T; Imbar T; Ben-Meir A
    J Assist Reprod Genet; 2022 Oct; 39(10):2249-2254. PubMed ID: 36114906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Covid-19 vaccination BNT162b2 temporarily impairs semen concentration and total motile count among semen donors.
    Gat I; Kedem A; Dviri M; Umanski A; Levi M; Hourvitz A; Baum M
    Andrology; 2022 Sep; 10(6):1016-1022. PubMed ID: 35713410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The BNT162b2 mRNA Covid-19 vaccine does not impair sperm parameters.
    Safrai M; Herzberg S; Imbar T; Reubinoff B; Dior U; Ben-Meir A
    Reprod Biomed Online; 2022 Apr; 44(4):685-688. PubMed ID: 35279377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive evaluation of inactivated SARS-CoV-2 vaccination on sperm parameters and sex hormones.
    Dong Y; Ba Z; Qin Y; Ma J; Li Y; Zhang Y; Yang A; Chen F
    Front Immunol; 2024; 15():1321406. PubMed ID: 38469318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics and Persistence of the Cellular and Humoral Immune Responses to BNT162b2 mRNA Vaccine in SARS-CoV-2-Naive and -Experienced Subjects: Impact of Booster Dose and Breakthrough Infections.
    Desmecht S; Tashkeev A; El Moussaoui M; Marechal N; Perée H; Tokunaga Y; Fombellida-Lopez C; Polese B; Legrand C; Wéry M; Mni M; Fouillien N; Toussaint F; Gillet L; Bureau F; Lutteri L; Hayette MP; Moutschen M; Meuris C; Vermeersch P; Desmecht D; Rahmouni S; Darcis G
    Front Immunol; 2022; 13():863554. PubMed ID: 35711445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 Vaccine Effects on Semen Parameters: A Systematic Review and Meta-Analysis.
    Omolaoye TS; Velilla PA; Moncada López JS; du Plessis SS; Cardona Maya WD
    Arch Esp Urol; 2022 Dec; 75(10):831-843. PubMed ID: 36651093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of COVID-19 vaccine on sperm quality.
    Barda S; Laskov I; Grisaru D; Lehavi O; Kleiman S; Wenkert A; Azem F; Hauser R; Michaan N
    Int J Gynaecol Obstet; 2022 Jul; 158(1):116-120. PubMed ID: 35128663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does mRNA SARS-CoV-2 vaccine detrimentally affect male fertility, as reflected by semen analysis?
    Lifshitz D; Haas J; Lebovitz O; Raviv G; Orvieto R; Aizer A
    Reprod Biomed Online; 2022 Jan; 44(1):145-149. PubMed ID: 34815157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of COVID-19 Incidence and Severity Among Adults Vaccinated With 2-Dose mRNA COVID-19 or Inactivated SARS-CoV-2 Vaccines With and Without Boosters in Singapore.
    Ng OT; Marimuthu K; Lim N; Lim ZQ; Thevasagayam NM; Koh V; Chiew CJ; Ma S; Koh M; Low PY; Tan SB; Ho J; Maurer-Stroh S; Lee VJM; Leo YS; Tan KB; Cook AR; Tan CC
    JAMA Netw Open; 2022 Aug; 5(8):e2228900. PubMed ID: 36018588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Humoral immunity against SARS-CoV-2 in workers of social health care centers of Castilla y León after vaccination with the BNT162b2 mRNA vaccine from Pfizer/Biontech.].
    Casas Fischer R
    Rev Esp Salud Publica; 2021 Oct; 95():. PubMed ID: 34690347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demographic and Clinical Factors Associated With Anti-SARS-CoV-2 Antibody Levels After 2 BNT162b2 mRNA Vaccine Doses.
    Nam SY; Jeon SW; Lee HS; Lim HJ; Lee DW; Yoo SS
    JAMA Netw Open; 2022 May; 5(5):e2212996. PubMed ID: 35587345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Boosting Dose of Pfizer-BioNtech mRNA Vaccine Against SARS-CoV-2 Does Not Affect Reproductive Outcomes in In-Vitro Fertilization Patients: A Cohort Study.
    Adler Lazarovits C; Smadja A; Kabessa M; Allouche Kam H; Nevo L; Godin M; Bentov Y; Beharier O; Esh Broder E; Holzer H; Hershko Klement A
    J Womens Health (Larchmt); 2023 Jan; 32(1):24-28. PubMed ID: 36413046
    [No Abstract]   [Full Text] [Related]  

  • 13. Association of a Third Dose of BNT162b2 Vaccine With Incidence of SARS-CoV-2 Infection Among Health Care Workers in Israel.
    Spitzer A; Angel Y; Marudi O; Zeltser D; Saiag E; Goldshmidt H; Goldiner I; Stark M; Halutz O; Gamzu R; Slobodkin M; Amrami N; Feigin E; Elbaz M; Furman M; Bronstein Y; Chikly A; Eshkol A; Furer V; Mayer T; Meijer S; Melloul A; Mizrahi M; Yakubovsky M; Rosenberg D; Safir A; Spitzer L; Taleb E; Elkayam O; Silberman A; Eviatar T; Elalouf O; Levinson T; Pozyuchenko K; Itzhaki-Alfia A; Sprecher E; Ben-Ami R; Henig O
    JAMA; 2022 Jan; 327(4):341-349. PubMed ID: 35006256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of inactivated SARS-CoV-2 vaccination on male fertility: A retrospective cohort study.
    Dong Y; Li X; Li Z; Zhu Y; Wei Z; He J; Cheng H; Yang A; Chen F
    J Med Virol; 2023 Jan; 95(1):e28329. PubMed ID: 36415120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerability of COVID-19 Infection and Messenger RNA Vaccination Among Patients With a History of Kawasaki Disease.
    Beckley M; Olson AK; Portman MA
    JAMA Netw Open; 2022 Aug; 5(8):e2226236. PubMed ID: 35960521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of Heterologous and Homologous Boosting With Inactivated COVID-19 Vaccine at 3 Months Compared With Homologous Boosting of BNT162b2 at 6 Months.
    Low EV; Tok PSK; Husin M; Suah JL; Tng BH; Thevananthan T; Appannan MR; Yahaya H; Mohd Zin S; Muhamad Zin F; Sivasampu S; Peariasamy KM
    JAMA Netw Open; 2022 Aug; 5(8):e2226046. PubMed ID: 35947381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers.
    Angel Y; Spitzer A; Henig O; Saiag E; Sprecher E; Padova H; Ben-Ami R
    JAMA; 2021 Jun; 325(24):2457-2465. PubMed ID: 33956048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of hematological parameters and thrombocytopenia following Pfizer-BioNTech (BNT162b2) SARS-CoV-2 vaccination.
    Algaissi A; Alamer E; Jeraiby M; Alomaish A; Elrhima O; Qumayi S; Qasir NA; Areeshi H; Masmali A; Alhazmi A
    Saudi Med J; 2022 Jun; 43(6):567-571. PubMed ID: 35675927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of SARS-CoV-2 Vaccines on Sperm Quality: Systematic Review.
    Li G; Zhang R; Song B; Wang C; Shen Q; He X; Cao Y
    JMIR Public Health Surveill; 2023 Dec; 9():e48511. PubMed ID: 37976132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of BNT162b2 Vaccine Third Dose Receipt With Incidence of SARS-CoV-2 Infection, COVID-19-Related Hospitalization, and Death Among Residents of Long-term Care Facilities, August to October 2021.
    Muhsen K; Maimon N; Mizrahi AY; Varticovschi B; Bodenheimer O; Cohen D; Dagan R
    JAMA Netw Open; 2022 Jul; 5(7):e2219940. PubMed ID: 35796153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.